Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

Scott A McConnell,1 Dharmik N Desai,1 Sejal P Faldu,1 Marjie L Hard,2 Angela Y Wehr,3 Peter J Weiden,1 Lisa von Moltke3 1Medical Affairs, Alkermes, Inc., Waltham, MA, 2Nuventra Pharma Sciences, Durham, NC, 3Clinical Research, Alkermes, Inc., Waltham, MA, USAThe recent publication by Salzman et al1...

Full description

Bibliographic Details
Main Authors: McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
aripiprazole
aripiprazole lauroxil
pharmacokinetics;long-acting injectables
Online Access:https://www.dovepress.com/long-acting-formulations-delivering-aripiprazole-beyond-single-value-c-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/long-acting-formulations-delivering-aripiprazole-beyond-single-value-c-peer-reviewed-article-NDT

Similar Items